PDIA3P expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.394200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.184770E-01
Normal-vs-Stage2
2.555600E-01
Normal-vs-Stage3
8.834000E-01
Normal-vs-Stage4
2.507200E-01
Stage1-vs-Stage2
3.228000E-01
Stage1-vs-Stage3
1.586190E-01
Stage1-vs-Stage4
9.484400E-01
Stage2-vs-Stage3
2.780800E-01
Stage2-vs-Stage4
3.709200E-01
Stage3-vs-Stage4
2.792200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.364400E-01
Normal-vs-AfricanAmerican
1.947590E-01
Normal-vs-Asian
5.105800E-01
Caucasian-vs-AfricanAmerican
9.571800E-01
Caucasian-vs-Asian
5.050000E-01
AfricanAmerican-vs-Asian
7.176200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.877800E-01
Normal-vs-Female
1.927440E-01
Male-vs-Female
6.406000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.008600E-01
Normal-vs-Age(41-60Yrs)
1.449810E-01
Normal-vs-Age(61-80Yrs)
3.202800E-01
Normal-vs-Age(81-100Yrs)
2.752800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.160800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.261000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.481600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.139600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.001800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.261200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.376200E-01
Normal-vs-Daily Drinker
3.898000E-01
Normal-vs-Weekly Drinker
4.958800E-01
Normal-vs-Occasional Drinker
2.298600E-01
Normal-vs-Social Drinker
1.196620E-01
Non Drinker-vs-Daily Drinker
6.832200E-01
Non Drinker-vs-Weekly Drinker
8.199000E-01
Non Drinker-vs-Occasional Drinker
1.647390E-01
Non Drinker-vs-Social Drinker
4.986200E-01
Daily Drinker-vs-Weekly Drinker
5.908600E-01
Daily Drinker-vs-Occasional Drinker
3.657600E-01
Daily Drinker-vs-Social Drinker
8.830000E-01
Weekly Drinker-vs-Occasional Drinker
1.870780E-01
Weekly Drinker-vs-Social Drinker
4.134400E-01
Occasional Drinker-vs-Social Drinker
3.733800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.971990E-01
Normal-vs-Grade 2
5.639900E-02
Normal-vs-Grade 3
5.098300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.952800E-01
Grade 1-vs-Grade 3
1.439430E-01
Grade 1-vs-Grade 4
1.971990E-01
Grade 2-vs-Grade 3
4.127400E-01
Grade 2-vs-Grade 4
5.639900E-02
Grade 3-vs-Grade 4
5.098300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.716400E-01
Normal-vs-NonDiabetic
2.108600E-01
Diabetic-vs-NonDiabetic
1.750790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.596440E-01
Normal-vs-NoPancreatitis
2.644400E-01
Pancreatitis-vs-NoPancreatitis
6.780800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.878950E-01
Normal-vs-N1
2.458800E-01
N0-vs-N1
8.786200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.031600E-02
Normal-vs-TP53-NonMutant
3.404000E-01
TP53-Mutant-vs-TP53-NonMutant
2.839600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
